Cleocin Phosphate
NDC Package 0009-3382-02
Package Information
Cleocin Phosphate is products are indicated in the treatment of serious infections caused by susceptible anaerobic bacteria.CLEOCIN PHOSPHATE products are also indicated in the treatment of serious infections due to susceptible strains of streptococci, pneumococci, and staphylococci. Marketed by Pharmacia & Upjohn Company Llc, this product is identified by NDC 0009-3382 and is authorized under FDA application NDA050639.
Identification & Billing
- RxCUI: 1737244 - clindamycin 300 MG in 2 ML Injection
- RxCUI: 1737244 - 2 ML clindamycin 150 MG/ML Injection
- RxCUI: 1737244 - clindamycin (as clindamycin phosphate) 300 MG per 2 ML Injection
- RxCUI: 1737244 - clindamycin 300 MG per 2 ML Injection
- RxCUI: 1737245 - Cleocin Phosphate 300 MG in 2 ML Injection
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 0009 - Pharmacia & Upjohn Company Llc
- 0009-3382 - Cleocin Phosphate
- 0009-3382-02 - 2 CARTON in 1 PACKAGE / 12 BAG in 1 CARTON / 50 mL in 1 BAG (0009-3382-01)
- 0009-3382 - Cleocin Phosphate
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0009-3382-02 identifies a specific commercial package of 2 carton in 1 package / 12 bag in 1 carton / 50 ml in 1 bag (0009-3382-01) of Cleocin Phosphate, labeled by Pharmacia & Upjohn Company Llc. This product is billed per "ML" milliliter and contains an estimated amount of 1200 billable units per package. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Pharmacia & Upjohn Company Llc on August 30, 1990. The current certification is valid through June 30, 2019.
How is this Pharmacia & Upjohn Company Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00009338202. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. There are 1200 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.